Artyc

Artyc is a logistics company specializing in advanced cold chain solutions, enhancing the transport of critical healthcare samples with precision and reliability. Their innovative products cater to the specific needs of healthcare institutions and clinical trials. Artyc operates in the cold chain logistics sector, focusing on transporting critical samples for healthcare facilities. Founded by Alice Caron, the company is headquartered in Delaware, US.

Artyc has undergone a strategic pivot towards enhancing its product offerings, particularly through the introduction of new technologies to improve logistics efficiency. In May 2022, the company raised seed funding from the investor SOSV, marking it as a target for investment. Its sole deal occurred on this date, which highlights an active engagement in the investment landscape. Artyc specializes in advanced cold chain logistics solutions, primarily with its Medstow 5L-Intercampus product, facilitating the transport of critical samples between healthcare facilities.

This product provides precision cooling for various temperature requirements including frozen, refrigerated, and controlled room temperature, while eliminating the need for dry ice. With real-time monitoring capabilities, it tracks temperature, location, and handling data during transport. Artyc's clientele includes healthcare institutions, clinical trial sites, and home-care teams across the United States, addressing key challenges in sample integrity and logistics efficiency. Artyc generates revenue through the direct sales of its Medstow products and logistics services to healthcare providers and clinical research organizations.

Their business model primarily revolves around B2B relationships, where clients purchase tailored equipment and services for cold chain management. Artyc also offers subscription options for ongoing support and compliance monitoring, with pricing reflecting the specialized nature of its products, ensuring the integrity of healthcare samples during transit. Revenue is further supported by partnerships with research institutions and healthcare networks. Looking ahead, Artyc aims to launch new products designed to enhance their cold chain logistics offerings, though specific release dates are not yet disclosed.

The company plans to expand its market reach beyond the United States, targeting international healthcare sectors by mid-2023. The recent seed funding raised in May 2022 will play a crucial role in facilitating these growth initiatives, allowing Artyc to invest in product development and market expansion efforts.